Photo of Megan Beaver

Megan F. Beaver is a counsel at Crowell & Moring’s San Francisco office, where she is a member of the firm’s Health Care Group. Megan’s practice focuses on health care regulatory matters, with an emphasis on state licensure and compliance issues. Megan works with national and regional health plans (including full service and specialty plans), Medicare Advantage, commercial and Medicaid health plans on a range of regulatory compliance matters, license filings, including plan-to-plan contracts and pharmacy benefit manager contracts, material modifications, and drafting and negotiating provider contracts. In addition, she assists and advises clients on state regulator parity investigations and responding to Department of Managed Health Care (“DMHC”) Office of Enforcement investigations. Megan has also assisted clients to obtain licensure as health care service plans under California’s Knox-Keene Health Care Service Plan Act.

Prior to joining the firm, Megan was Senior Corporate Counsel at Centene Corporation. In this role, Megan analyzed proposed, pending and recently enacted legislation, as well as agency guidance, to determine the impact on health plan operations. She advised plan leadership on how to implement and effectuate the required action. Megan also advised the California plan leadership on how to manage the dual authorities of government programs and plan licensure (i.e. Medicare/Medi-Cal and DMHC).

On July 2, 2025, the U.S. Department of Justice (DOJ) Civil Division and the U.S. Department of Health and Human Services (HHS) jointly announced the formation of a False Claims Act (FCA) Working Group. This new initiative underscores a coordinated federal enforcement strategy focused on identifying and addressing fraud in federally funded health care programs, particularly Medicare Advantage and Medicaid managed care. The announcement comes days after Matthew R. Galeotti, Head of DOJ’s Criminal Division, announced the results of the “largest coordinated health care fraud takedown in the history of the Department of Justice”  and the creation of a “Health Care Fraud Data Fusion Center” comprised of data specialists that will “break down information silos, using coordinated data analysis to enable our investigative teams to quickly identify and dismantle emerging fraud schemes.” Taken together, these announcements demonstrate the DOJ’s effort—in both civil and criminal divisions—to strengthen its collaboration with HHS to investigate and prosecute health care fraud.Continue Reading DOJ and HHS Launch FCA Working Group: Heightened Enforcement Risk for Health Care Entities

On September 14, 2023, the U.S. Department of Health and Human Services (“HHS”) published a proposed rule updating Section 504 of the Rehabilitation Act of 1973 (“Section 504”). The new rule entitled Discrimination on the Basis of Disability in Health and Human Service Programs or Activities(the “Proposed Rule”) is the first major regulatory update to Section 504 in nearly 50 years.  Section 504 prohibits discrimination against individuals on the basis of disability in programs and activities that receive Federal financial assistance (“FFA”) or are conducted by a Federal agency.  Section 504 covers all health care and human services programs and activities funded by HHS, from providers, like hospitals and doctors that accept Medicare or Medicare, to state child welfare programs, as well as Medicare Advantage Plans, and Medicaid Managed Care Plans.Continue Reading HHS Aims to Strengthen Anti-Discrimination Rules for Disabled Patients in New Proposed Rule